BioSpace News Archive

Press Releases

Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025

August 8, 2025
·
1 min read
Press Releases

CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025

August 8, 2025
·
3 min read
Press Releases

U.S. FDA grants accelerated approval to Boehringer’s HERNEXEOS® as first orally administered targeted therapy for previously treated patients with HER2-mutant advanced NSCLC

August 8, 2025
·
12 min read
Press Releases

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

August 8, 2025
·
8 min read
Press Releases

Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results

August 8, 2025
·
15 min read
Press Releases

Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Study of Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366 Showing Reductions in Viral Shedding Rate and Genital Lesion Rate in Recurrent Genital Herpes

August 8, 2025
·
12 min read
Press Releases

Anixa Biosciences Announces Dr. Robert Wenham will speak about Immunotherapy in surviving Ovarian Cancer at the 13th Annual Ovarcoming Cancer Conference

August 8, 2025
·
4 min read
Press Releases

FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

August 8, 2025
·
5 min read
Press Releases

Tenaya Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference

August 8, 2025
·
1 min read
Press Releases

AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation

August 8, 2025
·
14 min read